Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Newly-diagnosed Cancers”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01578967
What this trial is testing

Induction Chemo w/ABVD Followed by Brentuximab Vedotin Consolidation in Newly Diagnosed, Non-Bulky Stage I/II Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma, Adult
UNC Lineberger Comprehensive Cancer Center 41
Testing effectiveness (Phase 2)Active Not RecruitingNCT06521567
What this trial is testing

Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer

Who this might be right for
MelanomaHodgkin LymphomaHigh and Low Grade Glioma+9 more
GlaxoSmithKline 83
Testing effectiveness (Phase 2)Study completedNCT03030612
What this trial is testing

ARGX-110 in Combination With Azacytidine in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) or High Risk Myelodysplatic Syndrome (MDS)

Who this might be right for
Leukemia, Myeloid, AcuteMyelodysplastic Syndromes
OncoVerity, Inc. 38
Testing effectiveness (Phase 2)Looking for participantsNCT07654426
What this trial is testing

The CARDIOPROTECT Trial

Who this might be right for
Diffuse Large B-cell Lymphoma (DLBCL)CardiotoxicityLymphoma
Beth Israel Deaconess Medical Center 60
Early research (Phase 1)Ended earlyNCT00156299
What this trial is testing

Gene Expression During Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With Choline Magnesium Trisalicylate

Who this might be right for
Leukemia
Rutgers, The State University of New Jersey 15
Testing effectiveness (Phase 2)Study completedNCT02238925
What this trial is testing

An Open Label Phase II Pharmacokinetic and Pharmacodynamic Assessment of the Potential for QTc Prolongation Following First Induction Treatment With CPX-351 (Cytarabine:Daunorubicin) Liposome Injection in Acute Leukemias and MDS Patients

Who this might be right for
Acute Myeloid Leukemia (AML)Acute Lymphoblastic Leukemia (ALL)Myelodysplastic Syndrome (MDS)
Jazz Pharmaceuticals 26
Not applicableStudy completedNCT07701252
What this trial is testing

Digital Health Literacy and Oocyte Cryopreservation Among Women With Gynecological Cancer

Who this might be right for
Gynecological CancerOocyte CryopreservationDigital Health Literacy+1 more
Benha University 158
Testing effectiveness (Phase 2)Active Not RecruitingNCT04023526
What this trial is testing

Cusatuzumab Plus Azacitidine in Participants With Newly Diagnosed Acute Myeloid Leukemia Who Are Not Candidates for Intensive Chemotherapy

Who this might be right for
Leukemia, Myeloid, Acute
OncoVerity, Inc. 103
Not applicableStudy completedNCT00594815
What this trial is testing

Combined Immunochemotherapy Followed By Reduced Dose Radiation Therapy (RT) for Patients With Newly Diagnosed Primary Central Nervous System Lymphoma

Who this might be right for
Lymphoma
Memorial Sloan Kettering Cancer Center 52
Large-scale testing (Phase 3)UnknownNCT02362165
What this trial is testing

CyBorD vs. PAD in the Treatment of Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Sun Yat-sen University 236
Testing effectiveness (Phase 2)Looking for participantsNCT07428993
What this trial is testing

Evaluating Efficacy of B7-H3-CAR T Cells Administered at the End of Upfront Map Chemotherapy in Patients With Newly Diagnosed High-Risk Osteosarcoma

Who this might be right for
Pediatric Osteosarcoma
St. Jude Children's Research Hospital 41
Early research (Phase 1)Study completedNCT02010606
What this trial is testing

Phase I Study of a Dendritic Cell Vaccine for Patients With Either Newly Diagnosed or Recurrent Glioblastoma

Who this might be right for
GlioblastomaGlioblastoma MultiformeGlioma+2 more
Cedars-Sinai Medical Center 39
Testing effectiveness (Phase 2)Active Not RecruitingNCT02238808
What this trial is testing

See Whether Estrogen Can Slow the Growth of Some ER Positive Breast Cancers

Who this might be right for
Estrogen Receptor Positive Breast Cancer
AHS Cancer Control Alberta 19
Post-approval studies (Phase 4)Study completedNCT00686725
What this trial is testing

Standard Temodal (Temozolomide) Regimen Versus Standard Regimen Plus Early Postsurgery Temodal for Newly Diagnosed Glioblastoma Multiforme (Study P05572)

Who this might be right for
Glioblastoma
Merck Sharp & Dohme LLC 99
Testing effectiveness (Phase 2)UnknownNCT00363090
What this trial is testing

Alemtuzumab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV T-Cell Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Toronto Sunnybrook Regional Cancer Centre 84
Large-scale testing (Phase 3)Study completedNCT01026220
What this trial is testing

Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma

Who this might be right for
Childhood Nodular Lymphocyte Predominant Hodgkin LymphomaStage III Childhood Hodgkin LymphomaStage IV Childhood Hodgkin Lymphoma
Children's Oncology Group 166
Testing effectiveness (Phase 2)Active Not RecruitingNCT03456843
What this trial is testing

Therapeutic Effect of Cytoreductive Radical Prostatectomy in Men With Newly Diagnosed Metastatic Prostate Cancer

Who this might be right for
Stage IV Prostate Adenocarcinoma AJCC v7
Yale University 190
Large-scale testing (Phase 3)Ended earlyNCT00519090
What this trial is testing

Nilotinib vs Imatinib in Adult Patients With Philadelphia (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)

Who this might be right for
Myelogenous Leukemia
Novartis Pharmaceuticals 6
Large-scale testing (Phase 3)UnknownNCT00553124
What this trial is testing

Different Factors Affecting Patients With Newly Diagnosed Bladder Cancer

Who this might be right for
Bladder Cancer
University Hospital Birmingham 3,400
Testing effectiveness (Phase 2)Looking for participantsNCT06151080
What this trial is testing

Lenalidomide Combined With G-CHOP in the Treatment of Newly Diagnosed DLBCL With FL

Who this might be right for
DLBCL - Diffuse Large B Cell LymphomaFollicular Lymphoma
The First Affiliated Hospital of Xiamen University 38
Next Page